Top Markets
Coin of the day
Serina Therapeutics, Inc. Serina Therapeutics, Inc.

Serina Therapeutics, Inc.

SER
Rankning i aktier #26470
Serina Therapeutics, Inc., a biotechnology firm, focuses on creating... Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
Aktiekurs
$2.70
Marknadsvärde
$40.42M
Förändring (1 dag)
-1.28%
Förändring (1 år)
-48.17%
Land
US
Handel Serina Therapeutics, Inc. (SER)

Kategori

Aktiekurshistorik för Serina Therapeutics, Inc. (SER)
Högsta slutkurs: $2.72 den 2026-08-01

Lägsta slutkurs: $144.83 den 2018-11-01
Aktiekurshistorik för Serina Therapeutics, Inc. från 2018 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 0.36%
2025 -43.87%
2024 -59.83%
2023 -35.10%
2022 -9.36%
2021 -62.79%
2020 13.31%
2019 -58.69%
2018 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$543.01 37.69%
US
$1.03K 55.86%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$129.78 382.63%
US